GoodRx Holdings (GDRX) Price to Book (2020 - 2026)

GoodRx Holdings has disclosed Price to Book across 7 years of filings, most recently posting 1.51 for Q2 2026.

• In Q2 2026, Price to Book fell 44.63% year-over-year to 1.51; the TTM figure through Jun 2026 stood at 1.51 (down 44.63% YoY), while the FY2025 annual figure was 1.5, down 38.95% from the prior year.
• Price to Book came in at 1.51 for Q2 2026 at GoodRx Holdings, up from 1.06 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 9.74 in Q1 2022 to a low of 1.06 in Q1 2026.
• Average Price to Book over 5 years is 3.07, with a median of 2.5 recorded in 2024.
• Year-over-year, Price to Book slumped 87.86% in 2022 and soared 80.4% in 2024.
• Over 5 years, Price to Book stood at 2.27 in 2022, then soared by 52.62% to 3.47 in 2023, then declined by 29.11% to 2.46 in 2024, then tumbled by 38.95% to 1.5 in 2025, then gained by 0.86% to 1.51 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 1.51 in Q2 2026, 1.06 in Q1 2026, and 1.5 in Q4 2025.